| Antigen | 16-aa peptide from Human GT111; (Gene Accession #Q9BYW1) Designation (GT111-P, control peptide /blocking peptide) conjugated to KLH; Epitope location~ C-terminal, Cytoplasmic domain |
| Form | Antigen/blocking Peptide |
| Product Type | Peptide |
| SpCrossreactivity | Human GT111-P peptide sequence has no significant sequence homology with other gluts. It has not yet been cloned from other species. Since the epitope for GT111-A is at the C-terminus, the antibodies should detect the long and short isoforms (Glut11-AB, or Glut11-C etc) that differs at the N-terminus or other regions. Antibody crossreactivity in various species is not established. Control peptide, because of its low mol. Wt (<3 kDa), is not suitable for Western. It should be used for ELISA or antibody blocking experiments (use 5-10 ug control peptide per 1 ug of aff pure IgG or 1 ul antiserum) to confirm antibody specificity |
| SpeciesReactivity | Human |
| SugApplications | Control or blocking peptides are recommended for ELISA plate coating for direct ELISA testing of antibodies or competitive ELISA, and antibody blocking or neutralization. |